Results Announcements News Details

Advanced Enzyme Technologies Ltd consolidated sales down 6.68% on year in Q2FY2026, net profit dropped 14.72%

(08-Aug-26   15:41)

Advanced Enzyme Technologies Ltd share price softened by 1.88% to Rs 324.4 after the company's net profit declined by 14.72% to Rs 38.59 crore, while revenue from operations slipped slightly by 6.68% to Rs 189.79 crore in Q2FY26 over Q1FY26. The market capitalization of Biotechnology industry group stocks on BSE stood at Rs 48729.77 crore, tanking 25.06%. It has improved by 3.63% over last one week and ticked higher by 5.61% in last one month while the market capitalization of Advanced Enzyme Technologies Ltd has inched up 2.98% and 9.17% in the same period respectively. Profit before tax (PBT) of Advanced Enzyme Technologies Ltd stood at Rs 53.53 crore in Q2 FY26, slipping 2.50% year-on-year, and retreating 10.48% quarter-on-quarter. EBITDA came in at Rs 38 crore, crashing by 20.24% YoY and nosediving by 32.23% sequentially. Total expenses marginally dropped 1.08% to Rs 148.7 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 54.5 crore, marginally falling by 2.61% YoY, while employee benefits expense was at Rs 44.55 crore, ticking higher by 6.22% YoY. For the TTM ended FY26, revenue from operations improved 17.09% to Rs 745.76 crore, while net profit saw a strong growth of 29.59% to Rs 173.61 crore, compared to previous TTM. EBITDA soared by 16393% to Rs 194.23 crore, and PBT witnessed a strong rise of 24.11% to Rs 232.54 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 156.78 crore in FY26, as against Rs 142.5 crore in FY25. Advanced Enzyme Technologies Ltd gained 3.96% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.63% during the same period.